Details for New Drug Application (NDA): 209910
✉ Email this page to a colleague
The generic ingredient in CARBIDOPA is carbidopa; entacapone; levodopa. There are eighteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the carbidopa; entacapone; levodopa profile page.
Summary for 209910
Tradename: | CARBIDOPA |
Applicant: | Zydus Pharms |
Ingredient: | carbidopa |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 209910
Suppliers and Packaging for NDA: 209910
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARBIDOPA | carbidopa | TABLET;ORAL | 209910 | ANDA | Zydus Pharmaceuticals USA Inc. | 70710-1221 | 70710-1221-1 | 100 TABLET in 1 BOTTLE (70710-1221-1) |
CARBIDOPA | carbidopa | TABLET;ORAL | 209910 | ANDA | Zydus Lifesciences Limited | 70771-1355 | 70771-1355-1 | 100 TABLET in 1 BOTTLE (70771-1355-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | May 7, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription